Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
De-Stress and Perform is a nutraceutical capsule formulation developed by Gencor Pacific for the management of stress-induced premature ejaculation and the enhancement of male sexual health. The product is designed to improve quality of life by increasing ejaculatory control, enhancing sexual satisfaction, and reducing performance-related anxiety. It is currently undergoing clinical evaluation in a randomized, double-blind, placebo-controlled trial (NCT06571318) to measure its effects on the Perceived Stress Scale (PSS), Intravaginal Ejaculatory Latency Time (IELT), and various physiological markers including serum testosterone and cortisol levels. The supplement aims to address both the psychological and physiological components of male sexual performance through the modulation of stress responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on De-Stress and Perform.